Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sanofi-Aventis S.A. (OP: SNYNF ) 113.46 UNCHANGED Streaming Delayed Price Updated: 3:51 PM EDT, Sep 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sanofi-Aventis S.A. 3 Standout Stocks to Buy for the Next Bull Market July 18, 2024 These standout stocks to buy for a bull market offer promising potential for significant gains as market conditions continue to strengthen. Via InvestorPlace The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024 April 30, 2024 From Pinnacle Group International Via ACN Newswire 6 reasons to buy Teva Pharmaceuticals stock sooner than later February 26, 2024 Investors seeking a long-term and undervalued pharmaceutical play should take a close look at Teva Pharmaceuticals, and here are six reasons why Via MarketBeat Topics Lawsuit Exposures Financial Legal Teva Pharma is the way to play the re-rise of generic drugs November 28, 2023 Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth Via MarketBeat Pfizer and Sanofi shares fall, which one to scoop up? November 07, 2023 Pharmaceutical stocks aren't having a banner year; notably, two large pharmaceutical companies recently plunged to 52-week lows Via MarketBeat Exposures COVID-19 Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist August 01, 2023 Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Exscientia is the Sniper of the AI Drug Discovery Industry July 27, 2023 News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence DarioHealth is an AI-Powered Digital Therapeutics Play June 13, 2023 DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing December 06, 2022 From Singapore Economic Development Board (EDB)A*STAR Via ACN Newswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.